Despite the fact that US smokers are quitting at steadily higher rates, current value sales of NRT smoking cessation aids struggled over the review period. The reasons for this were twofold. One, private label, which claimed a majority share of sales since 2010, is only strengthening its hold on the category. GlaxoSmithKline is the only true branded player present, so comparison shopping is quite streamlined for price-sensitive consumers. The other major threat to NRT smoking cessation aids is...
Euromonitor International's NRT Smoking Cessation Aids in USA report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2008-2012, allowing you to identify the sectors driving growth. Forecasts to 2017 illustrate how the market is set to change.
Product coverage: NRT Gum, NRT Inhalators, NRT Lozenges, NRT Patches, Other NRT.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
Euromonitor International's NRT Smoking Cessation Aids in USA report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2008-2012, allowing you to identify the sectors driving growth. Forecasts to 2017 illustrate how the market is set to change.
Product coverage: NRT Gum, NRT Inhalators, NRT Lozenges, NRT Patches, Other NRT.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
- Get a detailed picture of the NRT Smoking Cessation Aids market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.
Headlines
Trends
Competitive Landscape
Prospects
Category Indicators
Table 1 Number of Smokers by Gender 2007-2012
Category Data
Table 2 Sales of NRT Smoking Cessation Aids by Category: Value 2007-2012
Table 3 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2007-2012
Table 4 NRT Gum Flavours: % Value Breakdown 2007-2012
Table 5 NRT Smoking Cessation Aids Company Shares by Value 2008-2012
Table 6 NRT Smoking Cessation Aids Brand Shares by Value 2009-2012
Table 7 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2012-2017
Table 8 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2012-2017
Cvs Caremark Corp in Consumer Health (usa)
Strategic Direction
Key Facts
Summary 1 CVS Caremark Corp: Key Facts
Summary 2 CVS Caremark Corp: Operational Indicators (Retail Pharmacy Segment)
Company Background
Production
Competitive Positioning
Summary 3 CVS Caremark Corp: Competitive Position 2012
Pfizer Consumer Healthcare Inc in Consumer Health (usa)
Strategic Direction
Key Facts
Summary 4 Pfizer Consumer Healthcare Inc: Key Facts
Summary 5 Pfizer Consumer Healthcare Inc: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 6 Pfizer Consumer Healthcare Inc: Competitive Position 2012
Walgreen Co in Consumer Health (usa)
Strategic Direction
Key Facts
Summary 7 Walgreen Co: Key Facts
Summary 8 Walgreen Co: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 9 Walgreen Co: Competitive Position 2012
Wal-mart Stores Inc in Consumer Health (usa)
Strategic Direction
Key Facts
Summary 10 Wal-Mart Stores Inc: Key Facts
Summary 11 Wal-Mart Stores Inc: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 12 Wal-Mart Stores Inc: Competitive Position 2012
Executive Summary
Consumer Health Continues Its Upward Climb
Manufacturing Issues Worsen Rather Than Improve
Private Label Producers Capitalise on Branded Product Challenges
Retailers Aim To Play A Broader Role in Consumers' Lives
OTC Rebound Will Drive Higher Growth Over the Forecast Period
Key Trends and Developments
Continuing the Balance Between Industry and Government
Baby Boomers Impact on Vitamins and Dietary Supplements
Growth in Protein Is Bulking Up in Strength
Manufacturing Issues Continue To Plague Consumer Health
Regulatory Prospects Alter Strategic Landscape
Market Indicators
Table 9 Consumer Expenditure on Health Goods and Medical Services 2007-2012
Table 10 Life Expectancy at Birth 2007-2012
Market Data
Table 11 Sales of Consumer Health by Category: Value 2007-2012
Table 12 Sales of Consumer Health by Category: % Value Growth 2007-2012
Table 13 Consumer Health Company Shares 2008-2012
Table 14 Consumer Health Brand Shares 2009-2012
Table 15 Penetration of Private Label by Category 2007-2012
Table 16 Sales of Consumer Health by Distribution Format: % Analysis 2007-2012
Table 17 Sales of Consumer Health by Category and Distribution Format: % Analysis 2012
Table 18 Forecast Sales of Consumer Health by Category: Value 2012-2017
Table 19 Forecast Sales of Consumer Health by Category: % Value Growth 2012-2017
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicine
Switches
Summary 13 OTC: Switches 2010-2012
Sources
Summary 14 Research Sources
Trends
Competitive Landscape
Prospects
Category Indicators
Table 1 Number of Smokers by Gender 2007-2012
Category Data
Table 2 Sales of NRT Smoking Cessation Aids by Category: Value 2007-2012
Table 3 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2007-2012
Table 4 NRT Gum Flavours: % Value Breakdown 2007-2012
Table 5 NRT Smoking Cessation Aids Company Shares by Value 2008-2012
Table 6 NRT Smoking Cessation Aids Brand Shares by Value 2009-2012
Table 7 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2012-2017
Table 8 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2012-2017
Cvs Caremark Corp in Consumer Health (usa)
Strategic Direction
Key Facts
Summary 1 CVS Caremark Corp: Key Facts
Summary 2 CVS Caremark Corp: Operational Indicators (Retail Pharmacy Segment)
Company Background
Production
Competitive Positioning
Summary 3 CVS Caremark Corp: Competitive Position 2012
Pfizer Consumer Healthcare Inc in Consumer Health (usa)
Strategic Direction
Key Facts
Summary 4 Pfizer Consumer Healthcare Inc: Key Facts
Summary 5 Pfizer Consumer Healthcare Inc: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 6 Pfizer Consumer Healthcare Inc: Competitive Position 2012
Walgreen Co in Consumer Health (usa)
Strategic Direction
Key Facts
Summary 7 Walgreen Co: Key Facts
Summary 8 Walgreen Co: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 9 Walgreen Co: Competitive Position 2012
Wal-mart Stores Inc in Consumer Health (usa)
Strategic Direction
Key Facts
Summary 10 Wal-Mart Stores Inc: Key Facts
Summary 11 Wal-Mart Stores Inc: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 12 Wal-Mart Stores Inc: Competitive Position 2012
Executive Summary
Consumer Health Continues Its Upward Climb
Manufacturing Issues Worsen Rather Than Improve
Private Label Producers Capitalise on Branded Product Challenges
Retailers Aim To Play A Broader Role in Consumers' Lives
OTC Rebound Will Drive Higher Growth Over the Forecast Period
Key Trends and Developments
Continuing the Balance Between Industry and Government
Baby Boomers Impact on Vitamins and Dietary Supplements
Growth in Protein Is Bulking Up in Strength
Manufacturing Issues Continue To Plague Consumer Health
Regulatory Prospects Alter Strategic Landscape
Market Indicators
Table 9 Consumer Expenditure on Health Goods and Medical Services 2007-2012
Table 10 Life Expectancy at Birth 2007-2012
Market Data
Table 11 Sales of Consumer Health by Category: Value 2007-2012
Table 12 Sales of Consumer Health by Category: % Value Growth 2007-2012
Table 13 Consumer Health Company Shares 2008-2012
Table 14 Consumer Health Brand Shares 2009-2012
Table 15 Penetration of Private Label by Category 2007-2012
Table 16 Sales of Consumer Health by Distribution Format: % Analysis 2007-2012
Table 17 Sales of Consumer Health by Category and Distribution Format: % Analysis 2012
Table 18 Forecast Sales of Consumer Health by Category: Value 2012-2017
Table 19 Forecast Sales of Consumer Health by Category: % Value Growth 2012-2017
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicine
Switches
Summary 13 OTC: Switches 2010-2012
Sources
Summary 14 Research Sources
